Detection of serum cardiac myosin light chains in acute experimental myocardial infarction: radioimmunoassay of cardiac myosin light chains.
- 1 December 1978
- journal article
- abstracts
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 58 (6), 1130-1136
- https://doi.org/10.1161/01.cir.58.6.1130
Abstract
To develop a more specific plasma test for myocardial infarction, antibodies specific for cardiac myosin light chains (CM-LC) were elicited that showed less than 3% cross-reactivity with skeletal muscle light chains. These antibodies were used to develop a radioimmunoassay for CM-LC that had a sensitivity of 20 ng (+/- 4 SD; P less than 0.001). Normal dog plasma showed no measurable concentrations of CM-LC (n = 6). Plasma samples from 10 dogs with experimental myocardial infarction produced by persistent left anterior descending coronary artery (LAD) occlusion were obtained at 0, 2, 4, 6, 24, 48 and 72 hours. CM-LC were first detectable in all 10 animals 6 hours after occlusion (97.98 +/- 14 ng/ml [mean +/- SEM]; P less than 0.001). Maximal CM-LC levels were usually obtained between 24 and 48 hours. Sham-operated open chest dogs (0--48 hours, n = 3) showed no measurable CM-LC in the plasma samples. Another group of 10 dogs were subjected to 5 hours of LAD occlusion, followed by reperfusion. In four dogs, CM-LC were detectable as early as 1 hour after reperfusion (81.88 +/- 37.75 ng/ml serum). Sera from all 10 dogs showed elevated levels of CM-LC (199.75 +/- 24.0 ng/ml) by 24 hours. Peak CM-LC concentrations were obtained in five dogs at 24 hours (247.0 +/- 35.28 ng/ml) and in another dog at 120 hours (245 ng/ml). Histochemical infarct size was determined to be 0.5--10% of the left ventricular mass at seven days by triphenyltetrazolium chloride staining. The specificity and sensitivity of this radioimmunoassay for detection of CM-LC, unique proteins to the heart, may be valuable in the diagnosis of myocardial infarction.This publication has 21 references indexed in Scilit:
- Clinical assessment of serum myosin light chains in the diagnosis of acute myocardial infarctionThe American Journal of Cardiology, 1978
- Experimental myocardial infarct imaging following intravenous administration of iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin.Circulation, 1978
- Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological diseaseAnnals of Neurology, 1978
- Radioimmunoassay for Creatine Kinase IsoenzymesScience, 1976
- Localization of cardiac myosin-specific antibody in myocardial infarction.JCI Insight, 1976
- Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction.JCI Insight, 1975
- Immunochemical analysis of the basic immunoglobulin in papular mucinosisImmunochemistry, 1972
- Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activityJCI Insight, 1971
- Evidence for Increased Serum Glutamic Oxalacetic Transaminase (SGO-T) Activity Following Graded Myocardial Infarcts in DogsCirculation, 1955
- Une micro-méthode de l’immuno-électrophorèseInternational Archives of Allergy and Immunology, 1955